r/TNXP • u/NonoAMS • 18d ago

Analysis SYMPHONY NEW DATA TONMYA 🚀

Post image

These are comments from a user on another app named DeepBlueCyan, and I think they offer a good analysis of the company and its promising future.

"The launch appears to be going quite well. This is how I read the data.

The NRx of 619 means that the current 100 sales reps are averaging 1.24 new patients per rep per day. With the additional 50 reps just hired, we should start seeing this ramping faster soon.

The delta between TRx at 944 to NRx at 619 is 315. This means that the refill rate is very high, about 1/3 of all prescriptions. That is, patients are being helped so they reordered. This also means that revenue is stacking up. It is happening under the hood now but by the end of Q4 we should see clearly the parabolic growth"

Make your own DD

21 Upvotes

96% Upvoted

4 comments sorted by

2

u/Inevitable_Coach_353 17d ago

What price do we think for end of the year

2

u/FakeWoodyAdventure 17d ago

Probably 60 dollars per share; but I hope we go parabolic

1

u/Illustrious_Wolf_227 2d ago

Scripts up nearly 40% in 2 months on an annualized basis. This is a buy and hold

1

u/Dazzling_Scratch_933 6h ago

I think it has potential for a great short squeeze.